Trademark Overview
On Monday, August 25, 2025, a trademark application was filed for LONQURJA with the United States Patent and Trademark Office. The USPTO has given the LONQURJA trademark a serial number of 99356583. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, August 25, 2025. This trademark is owned by Intellia Therapeutics, Inc.. The LONQURJA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for use with protein disorders and genetic diseases; Intravenous injectable gene therapy preparations for treating and managing swelling attacks; Therapeutic agents in the nature of CRISPR/Cas9 protein with guide RNAs targeting the KLKB1 gene to reduce production of plasma prekallikrein and control bradykinin generation
